These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34924904)

  • 1. An update of advanced nanoplatforms for Glioblastoma Multiforme Management.
    Amaral M; Cruz N; Rosa A; Nogueira B; Costa D; Santos F; Brazão M; Policarpo P; Mateus R; Kobozev Y; Reis CP
    EXCLI J; 2021; 20():1544-1570. PubMed ID: 34924904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoformulations for glioblastoma multiforme: a new hope for treatment.
    Ortiz R; Cabeza L; Perazzoli G; Jimenez-Lopez J; García-Pinel B; Melguizo C; Prados J
    Future Med Chem; 2019 Sep; 11(18):2459-2480. PubMed ID: 31544490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
    Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
    de Paula LB; Primo FL; Tedesco AC
    Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art.
    Di Filippo LD; Duarte JL; Luiz MT; de Araújo JTC; Chorilli M
    Curr Neuropharmacol; 2021; 19(6):787-812. PubMed ID: 32867643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy Based on Lipid Nanoparticles as Non-viral Vectors for Glioma Treatment.
    Luiz MT; Tofani LB; Araújo VHS; Di Filippo LD; Duarte JL; Marchetti JM; Chorilli M
    Curr Gene Ther; 2021; 21(5):452-463. PubMed ID: 33390137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma.
    Kim HS; Lee DY
    Brain Tumor Res Treat; 2022 Oct; 10(4):215-220. PubMed ID: 36347635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature.
    Yang Y; Cheng N; Luo Q; Shao N; Ma X; Chen J; Luo L; Xiao Z
    Int J Nanomedicine; 2023; 18():3663-3694. PubMed ID: 37427368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update.
    Hsu JF; Chu SM; Liao CC; Wang CJ; Wang YS; Lai MY; Wang HC; Huang HR; Tsai MH
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Nanotechnology in Glioblastoma Multiforme.
    Glaser T; Han I; Wu L; Zeng X
    Front Pharmacol; 2017; 8():166. PubMed ID: 28408882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies of recurrent glioblastoma and its molecular pathways 'Lock up the beast'.
    El-Khayat SM; Arafat WO
    Ecancermedicalscience; 2021; 15():1176. PubMed ID: 33680090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
    Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
    Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
    Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
    Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy.
    Gupta R; Sharma D
    ACS Chem Neurosci; 2019 Mar; 10(3):1157-1172. PubMed ID: 30715851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
    Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
    Shi D; Mi G; Shen Y; Webster TJ
    Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
    Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.